In the present study, we conducted an extensive analysis of human APOE4- and APOE3-expressing tauopathy mouse models to investigate the impact of selectively removing APOE4 from neurons on the development of major AD pathologies, including tau pathology, gliosis, neurodegeneration, neurodysfunction and myelin deficits. This evidence concerns the gene APOE and Alzheimer disease.